{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T01:45:42Z","timestamp":1768182342251,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2023A03J0348"],"award-info":[{"award-number":["2023A03J0348"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2024A03J1149"],"award-info":[{"award-number":["2024A03J1149"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2023A03J0347"],"award-info":[{"award-number":["2023A03J0347"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41417-025-00978-6","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:17:44Z","timestamp":1761135464000},"page":"55-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SATB1 regulates TXNIP inhibiting invasion and infiltration in T-cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"33","author":[{"given":"Lang","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anqiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runhui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaoyuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sida","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenqian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3437-1286","authenticated-orcid":false,"given":"Lihua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"978_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1341255","volume":"15","author":"Y Ren","year":"2024","unstructured":"Ren Y, Liang H, Huang Y, Miao Y, Li R, Qiang J, et al. Key candidate genes and pathways in T lymphoblastic leukemia\/lymphoma identified by bioinformatics and serological analyses. Front Immunol. 2024;15:1341255.","journal-title":"Front Immunol"},{"key":"978_CR2","doi-asserted-by":"crossref","unstructured":"Bardelli V, Arniani S, Pierini V, Di Giacomo D, Pierini T, Gorello P, et al. T-cell acute lymphoblastic leukemia: biomarkers and their clinical usefulness. Genes. 2021;12:1118.","DOI":"10.3390\/genes12081118"},{"key":"978_CR3","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1158\/1078-0432.CCR-18-0919","volume":"25","author":"S Saito","year":"2019","unstructured":"Saito S, Kikuchi J, Koyama D, Sato S, Koyama H, Osada N, et al. Eradication of central nervous system leukemia of T-cell origin with a brain-permeable LSD1 Inhibitor. Clin Cancer Res. 2019;25:1601\u201311.","journal-title":"Clin Cancer Res"},{"key":"978_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1182\/asheducation-2016.1.580","volume":"2016","author":"EA Raetz","year":"2016","unstructured":"Raetz EA, Teachey DT. T-cell acute lymphoblastic leukemia. Hematol Am Soc Hematol Educ Program. 2016;2016:580\u20138.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"978_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28371","volume":"68","author":"JH Chang","year":"2021","unstructured":"Chang JH, Poppe MM, Hua CH, Marcus KJ, Esiashvili N. Acute lymphoblastic leukemia. Pediatr Blood Cancer. 2021;68:e28371.","journal-title":"Pediatr Blood Cancer"},{"key":"978_CR6","first-page":"321","volume":"140","author":"P Lu","year":"2022","unstructured":"Lu P, Liu Y, Yang J, Zhang X, Yang X, Wang H, et al. Naturally selected CD7 CAR-T therapy without genetic manipulations for T-ALL\/LBL: first-in-human phase 1 clinical trial. Blood. 2022;140:321\u201334.","journal-title":"Blood"},{"key":"978_CR7","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1111\/cas.13303","volume":"108","author":"Y Kogure","year":"2017","unstructured":"Kogure Y, Kataoka K. Genetic alterations in adult T-cell leukemia\/lymphoma. Cancer Sci. 2017;108:1719\u201325.","journal-title":"Cancer Sci"},{"key":"978_CR8","doi-asserted-by":"crossref","unstructured":"Bongiovanni D, Saccomani V, Piovan E. Aberrant signaling pathways in T-cell acute lymphoblastic leukemia. Int J Mol Sci. 2017;18:1904.","DOI":"10.3390\/ijms18091904"},{"key":"978_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1182\/hematology.2022000337","volume":"2022","author":"KM O\u2019Dwyer","year":"2022","unstructured":"O\u2019Dwyer KM. Optimal approach to T-cell ALL. Hematol Am Soc Hematol Educ Program. 2022;2022:197\u2013205.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"978_CR10","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s12276-023-01019-8","volume":"55","author":"EH Choi","year":"2023","unstructured":"Choi EH, Park SJ. TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target. Exp Mol Med. 2023;55:1348\u201356.","journal-title":"Exp Mol Med"},{"key":"978_CR11","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/s41416-023-02442-4","volume":"129","author":"J Deng","year":"2023","unstructured":"Deng J, Pan T, Liu Z, McCarthy C, Vicencio JM, Cao L, et al. The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control. Br J Cancer. 2023;129:1877\u201392.","journal-title":"Br J Cancer"},{"key":"978_CR12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2174\/1389450118666170130145514","volume":"18","author":"NM Alhawiti","year":"2017","unstructured":"Alhawiti NM, Al Mahri S, Aziz MA, Malik SS, Mohammad S. TXNIP in metabolic regulation: physiological role and therapeutic outlook. Curr Drug Targets. 2017;18:1095\u2013103.","journal-title":"Curr Drug Targets"},{"key":"978_CR13","doi-asserted-by":"crossref","unstructured":"Persyn E, Wahlen S, Kiekens L, Taveirne S, Van Loocke W, Van Ammel E, et al. TXNIP promotes human NK cell development but is dispensable for NK cell functionality. Int J Mol Sci. 2022;23:11345.","DOI":"10.3390\/ijms231911345"},{"key":"978_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1538\/expanim.22-0126","volume":"72","author":"S Li","year":"2023","unstructured":"Li S, Ouyang G, Yuan L, Wu X, Zhang L. SRY-box transcription factor 9 modulates M\u00fcller cell gliosis in diabetic retinopathy by upregulating TXNIP transcription. Exp Anim. 2023;72:302\u201313.","journal-title":"Exp Anim"},{"key":"978_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.568574","volume":"10","author":"Y Chen","year":"2020","unstructured":"Chen Y, Ning J, Cao W, Wang S, Du T, Jiang J, et al. Research progress of TXNIP as a tumor suppressor gene participating in the metabolic reprogramming and oxidative stress of cancer cells in various cancers. Front Oncol. 2020;10:568574.","journal-title":"Front Oncol"},{"key":"978_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41419-022-04783-z","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Feng X, Yuan Y, Jiang J, Zhang P, Zhang B. Identification of a novel mechanism for reversal of doxorubicin-induced chemotherapy resistance by TXNIP in triple-negative breast cancer via promoting reactive oxygen-mediated DNA damage. Cell Death Dis. 2022;13:338.","journal-title":"Cell Death Dis"},{"key":"978_CR17","doi-asserted-by":"crossref","unstructured":"Oberacker T, Fritz P, Schanz M, Alscher MD, Ketteler M, Schricker S. Enhanced oxidative DNA-damage in peritoneal dialysis patients via the TXNIP\/TRX Axis. Antioxidants. 2022;11:1124.","DOI":"10.3390\/antiox11061124"},{"key":"978_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2024.04.223","volume":"219","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Chen Y, Liu Z, Zhou L, Huang J, Luo X, et al. TXNIP knockdown protects rats against bupivacaine-induced spinal neurotoxicity via the inhibition of oxidative stress and apoptosis. Free Radic Biol Med. 2024;219:1\u201316.","journal-title":"Free Radic Biol Med"},{"key":"978_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/em.22238","volume":"60","author":"U Plappert-Helbig","year":"2019","unstructured":"Plappert-Helbig U, Libertini S, Frieauff W, Theil D, Martus HJ. Gamma-H2AX immunofluorescence for the detection of tissue-specific genotoxicity in vivo. Environ Mol Mutagen. 2019;60:4\u201316.","journal-title":"Environ Mol Mutagen"},{"key":"978_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1631\/jzus.B2000289","volume":"22","author":"S Qiu","year":"2021","unstructured":"Qiu S, Huang J. MRN complex is an essential effector of DNA damage repair. J Zhejiang Univ Sci B. 2021;22:31\u20137.","journal-title":"J Zhejiang Univ Sci B"},{"key":"978_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1100-5","volume":"18","author":"L Bian","year":"2019","unstructured":"Bian L, Meng Y, Zhang M, Li D. MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment. Mol Cancer. 2019;18:169.","journal-title":"Mol Cancer"},{"key":"978_CR22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41580-019-0152-0","volume":"20","author":"R Scully","year":"2019","unstructured":"Scully R, Panday A, Elango R, Willis NA. DNA double-strand break repair-pathway choice in somatic mammalian cells. Nat Rev Mol Cell Biol. 2019;20:698\u2013714.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"978_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.molcel.2006.03.010","volume":"22","author":"P Pavan Kumar","year":"2006","unstructured":"Pavan Kumar P, Purbey PK, Sinha CK, Notani D, Limaye A, Jayani RS, et al. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol Cell. 2006;22:231\u201343.","journal-title":"Mol Cell"},{"key":"978_CR24","doi-asserted-by":"crossref","unstructured":"Glatzel-Pluci\u0144ska N, Piotrowska A, Dzi\u0119giel P, Podhorska-Oko\u019a\u00f3w M. The role of SATB1 in tumour progression and metastasis. Int J Mol Sci. 2019;20:4156.","DOI":"10.3390\/ijms20174156"},{"key":"978_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.biopha.2018.05.045","volume":"104","author":"KP Sunkara","year":"2018","unstructured":"Sunkara KP, Gupta G, Hansbro PM, Dua K, Bebawy M. Functional relevance of SATB1 in immune regulation and tumorigenesis. Biomed Pharmacother. 2018;104:87\u201393.","journal-title":"Biomed Pharmacother"},{"key":"978_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0850-x","volume":"19","author":"X Luo","year":"2019","unstructured":"Luo X, Xu L, Wu X, Tan H, Liu L. Decreased SATB1 expression promotes AML cell proliferation through NF-\u03baB activation. Cancer Cell Int. 2019;19:134.","journal-title":"Cancer Cell Int"},{"key":"978_CR27","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1007\/s13277-015-4638-x","volume":"37","author":"XD Luo","year":"2016","unstructured":"Luo XD, Yang SJ, Wang JN, Tan L, Liu D, Wang YY, et al. Downregulation of SATB1 increases the invasiveness of Jurkat Cell via activation of the WNT\/\u03b2-catenin signaling pathway in vitro. Tumour Biol. 2016;37:7413\u20139.","journal-title":"Tumour Biol"},{"key":"978_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.semcancer.2012.06.009","volume":"23","author":"T Kohwi-Shigematsu","year":"2013","unstructured":"Kohwi-Shigematsu T, Poterlowicz K, Ordinario E, Han HJ, Botchkarev VA, Kohwi Y. Genome organizing function of SATB1 in tumor progression. Semin Cancer Biol. 2013;23:72\u20139.","journal-title":"Semin Cancer Biol"},{"key":"978_CR29","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1128\/MCB.20.3.868-877.2000","volume":"20","author":"M Ramakrishnan","year":"2000","unstructured":"Ramakrishnan M, Liu WM, DiCroce PA, Posner A, Zheng J, Kohwi-Shigematsu T, et al. Modulated binding of SATB1, a matrix attachment region protein, to the AT-rich sequence flanking the major breakpoint region of BCL2. Mol Cell Biol. 2000;20:868\u201377.","journal-title":"Mol Cell Biol"},{"key":"978_CR30","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1093\/nar\/gkr023","volume":"39","author":"F Gong","year":"2011","unstructured":"Gong F, Sun L, Wang Z, Shi J, Li W, Wang S, et al. The BCL2 gene is regulated by a special AT-rich sequence binding protein 1-mediated long range chromosomal interaction between the promoter and the distal element located within the 3\u2019-UTR. Nucleic Acids Res. 2011;39:4640\u201352.","journal-title":"Nucleic Acids Res"},{"key":"978_CR31","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1182\/blood.2021013568","volume":"139","author":"Y Kogure","year":"2022","unstructured":"Kogure Y, Kameda T, Koya J, Yoshimitsu M, Nosaka K, Yasunaga JI, et al. Whole-genome landscape of adult T-cell leukemia\/lymphoma. Blood. 2022;139:967\u201382.","journal-title":"Blood"},{"key":"978_CR32","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1053\/j.seminoncol.2009.05.002","volume":"36","author":"CH Pui","year":"2009","unstructured":"Pui CH, Thiel E. Central nervous system disease in hematologic malignancies: historical perspective and practical applications. Semin Oncol. 2009;36:S2\u201316.","journal-title":"Semin Oncol"},{"key":"978_CR33","doi-asserted-by":"crossref","unstructured":"\u015aliwa-Tytko P, Kaczmarska A, Lejman M, Zawitkowska J. Neurotoxicity associated with treatment of acute lymphoblastic leukemia chemotherapy and immunotherapy. Int J Mol Sci. 2022;23:5515.","DOI":"10.3390\/ijms23105515"},{"key":"978_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.molimm.2021.10.016","volume":"140","author":"J Li","year":"2021","unstructured":"Li J, Muhammad J, Xie T, Sun J, Lei Y, Wei Z, et al. LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9\/CCL25. Mol Immunol. 2021;140:267\u201375.","journal-title":"Mol Immunol"},{"key":"978_CR35","doi-asserted-by":"publisher","first-page":"e143119.","DOI":"10.1172\/JCI143119","volume":"131","author":"X Gao","year":"2021","unstructured":"Gao X, Qin S, Wu Y, Chu C, Jiang B, Johnson RH, et al. Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia. J Clin Investig. 2021;131:e143119.","journal-title":"J Clin Investig"},{"key":"978_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.mito.2012.06.004","volume":"13","author":"J Zhou","year":"2013","unstructured":"Zhou J, Chng WJ. Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer. Mitochondrion. 2013;13:163\u20139.","journal-title":"Mitochondrion"},{"key":"978_CR37","first-page":"345","volume":"4","author":"SY Kim","year":"2007","unstructured":"Kim SY, Suh HW, Chung JW, Yoon SR, Choi I. Diverse functions of VDUP1 in cell proliferation, differentiation, and diseases. Cell Mol Immunol. 2007;4:345\u201351.","journal-title":"Cell Mol Immunol"},{"key":"978_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-62","volume":"13","author":"JA Morrison","year":"2014","unstructured":"Morrison JA, Pike LA, Sams SB, Sharma V, Zhou Q, Severson JJ, et al. Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer. Mol Cancer. 2014;13:62.","journal-title":"Mol Cancer"},{"key":"978_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2022.01.031","volume":"531","author":"Z Cheng","year":"2022","unstructured":"Cheng Z, Lu C, Wang H, Wang N, Cui S, Yu C, et al. Long noncoding RNA LHFPL3-AS2 suppresses metastasis of non-small cell lung cancer by interacting with SFPQ to regulate TXNIP expression. Cancer Lett. 2022;531:1\u201313.","journal-title":"Cancer Lett"},{"key":"978_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02639-2","volume":"22","author":"X Guo","year":"2022","unstructured":"Guo X, Huang M, Zhang H, Chen Q, Hu Y, Meng Y, et al. A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker. Cancer Cell Int. 2022;22:230.","journal-title":"Cancer Cell Int"},{"key":"978_CR41","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/abbs\/gmw045","volume":"48","author":"J Li","year":"2016","unstructured":"Li J, Xu X. DNA double-strand break repair: a tale of pathway choices. Acta Biochim et Biophys Sin. 2016;48:641\u20136.","journal-title":"Acta Biochim et Biophys Sin"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00978-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00978-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00978-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T23:02:14Z","timestamp":1768172534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00978-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1038\/s41417-025-00978-6","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study followed the approved protocol of the Guangdong Animal Testing Center (License number: SYXK 2016-0168). All animal procedures were approved by the Animal Ethics Committee of the RUIYE Laboratories and complied with the ARRIVE guidelines for humane animal research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical declarations"}}]}}